Anti-RAET1E antibody [EPR17443] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal RAET1E antibody. Carrier free. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
View Alternative Names
LETAL, N2DL4, ULBP4, UNQ1867/PRO4303, RAET1E, Retinoic acid early transcript 1E, Lymphocyte effector toxicity activation ligand, NKG2D ligand 4, RAE-1-like transcript 4, UL16-binding protein 4, N2DL-4, NKG2DL4
- IP
Supplier Data
Immunoprecipitation - Anti-RAET1E antibody [EPR17443] - BSA and Azide free (AB251318)
This data was developed using ab200662, the same antibody clone in a different buffer formulation.
RAET1E was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab200662 at 1/100 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (Input).
Lane 2 : ab200662 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab200662 in HeLa whole cell lysate.
Western blot was performed using ab200662 at 1/2000 dilution.
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-RAET1E antibody [EPR17443] (<a href='/en-us/products/primary-antibodies/raet1e-antibody-epr17443-ab200662'>ab200662</a>)
Predicted band size: 30 kDa
false
- WB
Supplier Data
Western blot - Anti-RAET1E antibody [EPR17443] - BSA and Azide free (AB251318)
This data was developed using ab200662, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-RAET1E antibody [EPR17443] (<a href='/en-us/products/primary-antibodies/raet1e-antibody-epr17443-ab200662'>ab200662</a>) at 1/5000 dilution
Lane 1:
HepG2 (Human liver hepatocellular carcinoma) cell lysate at 20 µg
Lane 2:
HeLa (Human epithelial cells from cervix adenocarcinoma) cell lysate at 20 µg
Lane 3:
MCF-7 (Human breast adenocarcinoma cell line) cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 30 kDa
Observed band size: 30 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-RAET1E antibody [EPR17443] - BSA and Azide free (AB251318)
This data was developed using ab200662, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RAET1E antibody [EPR17443] (<a href='/en-us/products/primary-antibodies/raet1e-antibody-epr17443-ab200662'>ab200662</a>) at 1/1000 dilution
All lanes:
Human fetal brain tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 30 kDa
Observed band size: 30 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-RAET1E antibody [EPR17443] - BSA and Azide free (AB251318)
This data was developed using ab200662, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RAET1E antibody [EPR17443] (<a href='/en-us/products/primary-antibodies/raet1e-antibody-epr17443-ab200662'>ab200662</a>) at 1/1000 dilution
Lane 1:
C6 (Rat glial tumor cells) cell lysate at 10 µg
Lane 2:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) cell lysate at 10 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma) cell lysate at 10 µg
Lane 4:
NIH/3T3 (Mouse embyro fibroblast cells) cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 30 kDa
Observed band size: 30 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-RAET1E antibody [EPR17443]
Reactivity data
Product details
ab251318 is the carrier-free version of ab200662.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RAET1E plays a role in immune surveillance. It is involved in the activation of NK cells when it binds to the NKG2D receptor. This interaction is part of the body's defense mechanism against transformed or infected cells. RAET1E operates in isolation rather than as part of a larger protein complex which allows it to independently initiate the immune response when detecting harmful cells.
Pathways
RAET1E functions within the innate immune response pathway. It works closely with the NKG2D signaling pathway which is important for the activation of cytotoxic activities in immune cells. RAET1E through its binding to NKG2D facilitates the destruction of malignant cells. This connection places RAET1E alongside other similar NKG2D ligands such as MIC and other ULBP family proteins which contribute to the activation of NK and T cells.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Molecular cancer research : MCR 21:1107-1119 PubMed37409971
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com